A Dose-Escalating Study of Ro 31-8959 ( HIV Protease Inhibitor ) in Patients With HIV Disease.
Clinical trial NCT00002111 · COMPLETED
Trial details
- NCT number
- NCT00002111
- Sponsor
- Stanford University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.